Key facts
- This page summarizes Scott Thomas Jackson's Form 4 filing for MACROGENICS INC (MGNX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 23 May 2024, 17:16.
Scott Thomas Jackson - 21 May 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)
- Reporting relationship
- Director
- Issuer ticker
- MGNX
- Reported as of
- 21 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 May 2024, 17:16:03 UTC
- Prior SEC filing
- 22 May 2024
- Next SEC filing
- 30 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lynn M. Cilinski, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Scott Thomas Jackson filed Form 4 for MACROGENICS INC (MGNX) on 23 May 2024.
Change
- Previous filing in this sequence was filed on 22 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MGNX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +6,500
- Change %
- Price
- $0.000000
- Shares after
- 6,500
- Date
- 21 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,500
- Exercise price
- $0.000000
- Footnotes
- F1, F2
MGNX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +16,500
- Change %
- Price
- $0.000000
- Shares after
- 16,500
- Date
- 21 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,500
- Exercise price
- $4.26
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
Footnote F3
The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.